Skip to search formSkip to main contentSkip to account menu

Juvenile astrocytoma

Known as: Pediatric Astrocytic Neoplasm, Pediatric Astrocytic Tumor, Childhood Astrocytic Tumor 
An astrocytic tumor appearing before the age of twenty one without designation of benign or malignant nor designated location.
National Institutes of Health

Related topics

Related topics

9 relations
AstrocytesCentral Nervous SystemNeoplastic CellNervous system structure

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
PTPS-21MAPK PATHWAY INHIBITOR THERAPY FOR PROGRESSIVE PEDIATRIC ASTROCYTOMAS
BACKGROUND: Brain tumors are the most common solid tumor in childhood and astrocytomas account for the largest proportion of… 
2013
2013
Expression of histone acetylases p300 and PCAF in pediatric astrocytomas
ObjectsThe protein 300 (p300) and p300/CBP-binding protein-associated factor (PCAF) are enzymes with histone acetyltransferase… 
2005
2005
Expression of Mer and Axl receptor tyrosine kinases in pediatric astrocytoma patients
1555 Background: Tumors of the central nervous system (CNS) are the second most common cause of pediatric cancer and are the… 
2004
2004
Cerebrospinal metastases in malignant childhood astrocytomas
Over a period of five years, antemortem diagnosis of leptomeningeal spread was made in six of thirteen children with high grade… 
2002
2002
MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression.
During the last decade, the aberrant expression of normal testicular proteins in neoplastically transformed cells became common… 
1999
1999
Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Apoptosis is a physiological process wherein the cell initiates a sequence of events culminating in the fragmentation of its DNA… 
1998
1998
Interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-1 receptor type I, IL-1 receptor antagonist, and TGF-beta 1 mRNAs in pediatric astrocytomas, ependymomas, and primitive neuroectodermal tumors.
Interleukin-1 alpha (IL-1 alpha), IL-1 beta, interleukin-1 receptor type I (IL-1RI, signaling receptor), and IL-1 receptor… 
1992
1992
Proliferative potential and outcome in pediatric astrocytic tumors
SummaryIn 43 pediatric patients (29 male, 14 female) with primary astrocytic tumors of the central nervous system (CNS), the… 
1990
1990
Immunophenotyping of childhood astrocytomas with a library of monoclonal antibodies
Immunophenotype (IP) analysis of 14 childhood glial tumors was performed with a library of 16 monoclonal antibodies (MAbs) using… 
1983
1983
A study of glial fibrillary acidic protein (GFAP) in childhood brain tumours
A retrospective study of 366 primary brain tumours in childhood has been carried out. GFAP was detected in juvenile astrocytoma… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)